PRISM AI
Transthyretin Amyloidosis Treatment Market Size, Share & Trends Report

Transthyretin Amyloidosis Treatment Market (2025 - 2030) Size, Share & Trends Analysis Report By Therapy (Targeted Therapy, Supportive Therapy, Pipeline Therapy), By Type (ATTR-PN, ATTR-CM), By Disease, By Distribution Channel, By Region, And Segment Forecasts

Revenue, 2024 (US$M)
$6,644.3
Forecast, 2030 (US$M)
$16,526.5
CAGR, 2025 - 2030
13.9%
Report Coverage
Worldwide
Related Markets
Global transthyretin amyloidosis treatment market, by region, 2018-2030 (US$M)
by regions
Global transthyretin amyloidosis treatment market share,2024 & 2030 (%, US$M)
by region
Global transthyretin amyloidosis treatment market: Opportunity assessment by country
by region
Global transthyretin amyloidosis treatment market, by region, 2024 (US$M)
by region
Top 10 countries: Global transthyretin amyloidosis treatment market size, 2024 (US$M)
by region
Global transthyretin amyloidosis treatment market, by therapy, 2018-2030 (US$M)
by region
Global transthyretin amyloidosis treatment market, by type , 2018-2030 (US$M)
by region
Global transthyretin amyloidosis treatment market, by disease type, 2018-2030 (US$M)
by region
Global transthyretin amyloidosis treatment market, by distribution channel, 2018-2030 (US$M)
by region
Global transthyretin amyloidosis treatment market, by region, 2018-2030 (US$M)
Global real world evidence solutions market size, by region, 2018-2030 (US$M)

Trusted market insights - try a free sample

See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.

logo
GDPR & CCPA Compliant
logo
ISO 9001 Certified
logo
ISO 27001 Certified
logo
ESOMAR Member
Grand View Research is trusted by industry leaders worldwide
client logo
client logo
client logo
client logo
client logo
client logo